Search

Displaying results 6001 - 6010 of 9705 in total
  1. Drug

    Eftansomatropin alfa

    go.drugbank.com/drugs/DB18460
    Investigational

    Eftansomatropin alfa (GX-H9) comprises a recombinant human growth hormone fused to hyFc, a synthetic hybrid Fc fragment.

  2. Drug

    Esuberaprost

    go.drugbank.com/drugs/DB18464
    Investigational

    Esuberaprost (GP-1681), a drug intended for participants with pulmonary arterial hypertension, was under investigation in clinical trial NCT03657095 to evaluate its efficacy and safety.

  3. Drug

    Spevatamig

    go.drugbank.com/drugs/DB18471
    Investigational

    PT886 is a bispecific antibody against Claudin 18.2 and cluster of differentiation 47 (CD47)

  4. Drug

    PT217

    go.drugbank.com/drugs/DB18472
    Investigational

    PT217 is a bispecific Antibody against DLL3 and CD47

  5. Drug

    ASP-2138

    go.drugbank.com/drugs/DB18473
    Investigational

    ASP-2138 is a bispecific antibody directed against CLDN18.2 and T cell receptor complex CD3

  6. Drug

    VBI-1901

    go.drugbank.com/drugs/DB18476
    Investigational

    VBI-1901 is a bivalent cytomeglaovirus gB/pp65 enveloped virus-like particles

  7. Drug

    ALT-P1

    go.drugbank.com/drugs/DB18485
    Investigational

    ALT-P1 is a long-acting recombinant human growth hormone fused to an alpha1-antitrypsin variant. It is under investigation for the treatment of growth hormone deficiency.

  8. Drug

    KT-253

    go.drugbank.com/drugs/DB18487
    Investigational

    KT-253 is a selective heterobifunctional small molecule degrader of mouse double minute 2 (MDM2).

  9. Drug

    DMP-777

    go.drugbank.com/drugs/DB18488
    Experimental

    DMP-777 is a selective inhibitor of polymorphonuclear leukocyte (PMN) elastase.

  10. Drug

    Elenestinib

    go.drugbank.com/drugs/DB18489
    Investigational

    Elenestinib is a selective KIT inhibitor.